Data / Research funding / Tickborne Diseases
Tickborne Diseases: 363 NIH awards ($433.4M) to 142 organizations
363 NIH awards ($433.4M) in the NIH spending category Tickborne Diseases, to 142 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
363 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Vermont Biomedical Research Network-Vermont INBRE | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,534,463 | September 30, 2001 | June 30, 2030 | FRANCKLYN, CHRISTOPHER S | reporter.nih.gov |
| Lyme Disease: B cell epitope discovery and mechanisms of antibody protection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,722,146 | September 16, 2019 | September 15, 2024 | MANTIS, NICHOLAS J. | reporter.nih.gov |
| B Cell Epitope Discovery and Mechanisms of Antibody Protection: Responses to Dengue 4, Powassan, Chikungunya, and Venezuelan Equine Encephalitis Viruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,634,396 | September 16, 2023 | September 15, 2024 | FREMONT, DAVED | reporter.nih.gov |
| Comparative effectiveness and complications of intravenous ceftriaxone compared with oral doxycycline in Lyme meningitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,573,382 | September 1, 2021 | August 31, 2027 | NIGROVIC, LISE E. | reporter.nih.gov |
| Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,526,401 | July 17, 2020 | June 5, 2025 | SAKUNTABHAI, ANAVAJ | reporter.nih.gov |
| Comparative systems biology of apicomplexan cell division | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,447,470 | July 21, 2022 | June 30, 2027 | GUBBELS, MARC-JAN | reporter.nih.gov |
| DNA damage response and repair of a broken chromosome | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,083,668 | June 1, 2018 | May 31, 2028 | HABER, JAMES E | reporter.nih.gov |
| Evaluation of an OMV-adjuvanted Chimeritrope Vaccine against Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $4,961,891 | September 30, 2018 | September 29, 2023 | MORICI, LISA | reporter.nih.gov |
| IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,866,733 | July 1, 2022 | June 30, 2027 | ERICKSON, LOREN D | reporter.nih.gov |
| Heritable immunization of the white-footed mouse reservoir of Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,657,626 | September 1, 2021 | August 31, 2026 | ESVELT, KEVIN | reporter.nih.gov |
| IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,621,686 | July 1, 1984 | May 31, 2028 | PLATTS-MILLS, THOMAS A. | reporter.nih.gov |
| Development of the INI-4001 and INI-2002 adjuvants within the context of a vaccine to prevent Lyme disease. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $4,583,801 | September 30, 2018 | September 29, 2024 | EVANS, JAY | reporter.nih.gov |
| Molecular elucidation of the Francisella tularensis virulence mechanism | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,049,782 | May 21, 2021 | April 30, 2027 | SCHUMACHER, MARIA | reporter.nih.gov |
| Innovations in Functional B Cell Epitope Discovery for Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $4,031,164 | September 16, 2024 | September 15, 2026 | MANTIS, NICHOLAS | reporter.nih.gov |
| Functional B-cell Epitope Discovery for Arthropod-Borne Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,708,329 | September 16, 2024 | September 15, 2027 | reporter.nih.gov | |
| PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,656,578 | March 24, 2021 | July 31, 2027 | MACLEOD, IAIN JAMES | reporter.nih.gov |
| Fosinopril analogs for the treatment of human babesiosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,646,365 | April 21, 2021 | March 31, 2027 | BEN MAMOUN, CHOUKRI | reporter.nih.gov |
| The Tick Immune Response During Microbial Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,501,084 | December 1, 2015 | May 31, 2027 | PEDRA, JOAO | reporter.nih.gov |
| Rickettsia-host interface and multiple paths to invasion | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,450,818 | June 15, 2016 | May 31, 2027 | RAHMAN, MOHAMMED SAYEEDUR | reporter.nih.gov |
| Microbial Determinants of Excessive Inflammation and Severe Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,315,179 | September 19, 2025 | August 31, 2029 | STRLE, KLEMEN | reporter.nih.gov |
| The roles of ceramide and its derivatives in A. phagocytophilum pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,301,707 | June 6, 2018 | May 31, 2028 | CARLYON, JASON A | reporter.nih.gov |
| B cell Epitope Discovery and Mechanisms of Antibody Protection for Enterovirus and Bunyavirus Entry Proteins | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,291,808 | September 16, 2024 | September 15, 2026 | reporter.nih.gov | |
| A novel Lyme disease vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,240,479 | June 7, 2022 | May 31, 2027 | FIKRIG, EROL | reporter.nih.gov |
| Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,201,446 | May 15, 2020 | April 30, 2026 | HU, LINDEN T | reporter.nih.gov |
| Rational development of a vaccine against tick-borne rickettsioses | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,166,318 | August 1, 2022 | July 31, 2027 | FANG, RONG MEGAN | reporter.nih.gov |
| Analysis of a novel Crimean-Congo hemorrhagic fever vaccine and its mechanism of protection in rodent models | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,145,040 | August 25, 2022 | July 31, 2026 | SCHNELL, MATTHIAS JOHANNES | reporter.nih.gov |
| A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,023,104 | June 24, 2020 | June 30, 2025 | ARNABOLDI, PAUL MICHAEL | reporter.nih.gov |
| DEVELOPMENT OF COVALENTLY BOUND HYALURONIC ACID AS AN ADJUVANT FOR MULTIVALENT LYME DISEASE VACCINE | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $2,999,999 | September 30, 2024 | September 29, 2027 | PETILLO, PETER A | reporter.nih.gov |
| Intranasal Vaccine Against Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,988,409 | July 12, 2022 | June 30, 2026 | GOMES-SOLECKI, MARIA | reporter.nih.gov |
| Mechanisms of SFG Rickettsia-Host Interactions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,971,223 | August 12, 2021 | July 31, 2030 | LAMASON, REBECCA L | reporter.nih.gov |
| Mechanisms of Rickettsia invasion, intracellular survival, and actin-based motility | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,937,177 | September 1, 2014 | August 31, 2028 | WELCH, MATTHEW D | reporter.nih.gov |
| The roles of Lyme spirochete adhesins in hematogenous dissemination | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,886,252 | February 10, 2022 | January 31, 2027 | COBURN, JENIFER L | reporter.nih.gov |
| Structure-Function Relationships in the Spirochetal Flagellar Motor | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,865,323 | February 15, 2010 | May 31, 2027 | LIU, JUN | reporter.nih.gov |
| High accuracy automated tick classification using computer vision | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,863,916 | April 18, 2022 | September 30, 2026 | GOODWIN, AUTUMN | reporter.nih.gov |
| Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,862,279 | July 15, 2020 | June 30, 2026 | GEISBERT, THOMAS WILLIAM | reporter.nih.gov |
| Multivalent Tick-Microbe targeted Lyme disease vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,836,037 | July 20, 2020 | June 30, 2027 | PAL, UTPAL | reporter.nih.gov |
| Genetic architecture of host response to tickborne disease in Peromyscus leucopus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,831,395 | September 17, 2020 | August 31, 2025 | LONG, ANTHONY DOUGLAS | reporter.nih.gov |
| Polymeric matrix loaded with tick repellent or toxic compositions for incorporation into fabrics or for granular dispersal | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,775,723 | September 23, 2022 | August 31, 2025 | BANFIELD, MICHAEL GILBERT | reporter.nih.gov |
| Hybrid ELISA: Simple and specific one-tier assay for Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,764,666 | March 6, 2019 | August 31, 2027 | LEVIN, ANDREW E. | reporter.nih.gov |
| Molecular basis of immunity to tick-borne rickettsioses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,758,756 | September 1, 2021 | August 31, 2027 | KIM, HWAN KEUN | reporter.nih.gov |
| Targeting Cyclic Dinucleotide Signaling Pathways to Interrupt the Nature Cycle of Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,734,150 | June 9, 2020 | May 31, 2026 | YANG, X. FRANK | reporter.nih.gov |
| Host Metabolic Biosignatures for the Diagnosis of Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,695,774 | June 19, 2019 | May 31, 2025 | BELISLE, JOHN T | reporter.nih.gov |
| Regulatory Pathways in Borrelial Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,694,240 | August 5, 2022 | July 31, 2027 | SKARE, JON T | reporter.nih.gov |
| Understanding alpha-gal red meat allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,615,501 | September 24, 2018 | January 31, 2029 | COMMINS, SCOTT PALMER | reporter.nih.gov |
| Tick Saliva and Pathogen Transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,544,342 | May 9, 2018 | June 30, 2029 | PEDRA, JOAO | reporter.nih.gov |
| Vaccines for Prevention of RG3 and RG4 Emerging Tickborne Viral Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,523,497 | August 20, 2021 | July 31, 2026 | VERARDI, PAULO H | reporter.nih.gov |
| Development of vaccines targeting a tick-borne phlebovirus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,499,856 | July 10, 2020 | June 30, 2025 | BATES, PAUL | reporter.nih.gov |
| Toward novel therapies against Lyme disease through the inhibition of lysinoalaine cross-linking in the bacterial flagella. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,405,876 | August 16, 2021 | July 31, 2025 | CRANE, BRIAN R | reporter.nih.gov |
| Cyclic di-AMP-dependent signaling in tickborne relapsing fever Borrelia | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,380,916 | August 8, 2022 | July 31, 2027 | BLEVINS, JON SCOTT | reporter.nih.gov |
| Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,344,769 | September 8, 2020 | August 31, 2025 | HU, LINDEN T | reporter.nih.gov |
| Virulence Mechanisms of Multifunctional Borrelial Proteins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,337,463 | June 15, 2020 | August 16, 2024 | GARCIA, BRANDON LEE | reporter.nih.gov |
| Reassortment of Bunyavirus in ticks and animal models | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,326,633 | August 19, 2022 | July 31, 2027 | JUNG, JAE U | reporter.nih.gov |
| Investigations of Lyme spirochete transmission as a complex network of microbial and ecological interactions | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,315,379 | September 16, 2022 | July 31, 2027 | COURET, JANNELLE | reporter.nih.gov |
| Identity, function and control of Francisella effectors encoded outside its pathogenicity island | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,279,849 | July 1, 2019 | June 30, 2025 | MOUGOUS, JOSEPH DAVID | reporter.nih.gov |
| Development of a Virus-Like Particle Vaccine for Powassan Virus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,265,539 | June 1, 2020 | May 31, 2026 | HIRSCH, ALEC J | reporter.nih.gov |
| SFTSV nonstructural protein NSs-mediated immunopathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,260,994 | July 1, 2018 | June 30, 2024 | JUNG, JAE U | reporter.nih.gov |
| Develop a candidate subunit vaccine for Powassan Virus and West Nile virus adjuvanted with Alhydroxiquim-II | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $2,258,969 | September 30, 2018 | September 29, 2023 | DAVID, SUNIL | reporter.nih.gov |
| Tickborne SFTS Virus Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,258,000 | August 3, 2020 | July 31, 2026 | JUNG, JAE U | reporter.nih.gov |
| US-UK Collab: Modelling reassortment at the cellular, clinical, and phylogenetic level in emerging Bunyaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,245,998 | July 1, 2021 | June 30, 2027 | MOLINA-PARIS, CARMEN | reporter.nih.gov |
| Developing New Statistical Methods for Vector-Borne Disease Surveillance to Improve Accuracy while Reducing Cost | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,240,192 | September 19, 2023 | July 31, 2028 | SELF, STELLA COKER WATSON | reporter.nih.gov |
| ANTIBODY-BASED PROTECTION AGAINST FLAVIVIRUSES | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,212,878 | September 15, 2007 | January 31, 2029 | DIAMOND, MICHAEL S | reporter.nih.gov |
| OspC and its role in defining host range and dissemination properties | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,211,024 | August 1, 2022 | July 31, 2026 | MARCONI, RICHARD T | reporter.nih.gov |
| SpoVG and PlzA Regulation of Lyme Disease Spirochete Infection Processes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,207,935 | April 1, 2020 | March 31, 2026 | STEVENSON, BRIAN | reporter.nih.gov |
| Composition, Atomic Structure and Function of the Francisella Type 6 Secretion System, a Distinct Subtype Essential for Phagosomal Escape, Intracellular Replication, and Virulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,198,656 | September 21, 2020 | August 31, 2025 | HORWITZ, MARCUS AARON | reporter.nih.gov |
| Rocky Mountain Spotted Fever Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,192,703 | September 1, 2021 | August 31, 2027 | GANTA, ROMAN R. | reporter.nih.gov |
| Borrelia gene products critical for natural infection cycle | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,181,619 | July 1, 2009 | July 31, 2025 | PAL, UTPAL | reporter.nih.gov |
| Role of IgE in human disease and immunity to ticks | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,139,543 | March 20, 2024 | January 31, 2026 | SMITH, SCOTT ALAN | reporter.nih.gov |
| Mechanisms of viral RNA maturation by co-opting cellular exonucleases | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,134,101 | June 1, 2023 | May 31, 2027 | KIEFT, JEFFREY S | reporter.nih.gov |
| Intra-tick and intra-host infection dynamics of a tick-borne bunyavirus | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,092,645 | July 1, 2022 | June 30, 2027 | HERMANCE, MEGHAN ELIZABETH | reporter.nih.gov |
| PlzA, cyclic-di-GMP and the enzootic cycle for Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,090,540 | November 18, 2022 | October 31, 2027 | MARCONI, RICHARD T | reporter.nih.gov |
| Mechanism and Inhibition of Thogotovirus Entry | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,085,008 | November 22, 2022 | October 31, 2027 | BOON, ADRIANUS CM | reporter.nih.gov |
| New tools for tick-borne pathogen surveillance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,075,697 | December 8, 2022 | November 30, 2027 | OLIVER, JONATHAN D | reporter.nih.gov |
| Field trial and modeling of transmission blocking vaccine to prevent Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,072,628 | June 19, 2019 | May 31, 2025 | BROWN, GRANT D | reporter.nih.gov |
| The roles of Anaplasma phagocytophilum surface proteins in infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,062,336 | July 15, 2007 | June 30, 2027 | CARLYON, JASON A | reporter.nih.gov |
| Tick-Pathogen Interactions: Exploring the Intersection between Stress Responses and Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,049,089 | July 11, 2022 | June 30, 2027 | SHAW, DANA KATHLEEN | reporter.nih.gov |
| Vanderbilt University Medical Center (VUMC) CoFAR Clinical Research Center | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,036,652 | March 14, 2024 | February 28, 2031 | BACHARIER, LEONARD B | reporter.nih.gov |
| Germline Transformation of Ticks | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,013,002 | May 11, 2023 | April 30, 2028 | GULIA-NUSS, MONIKA | reporter.nih.gov |
| FH-Fc as a Pre-Exposure Prophylactic for Tickborne Disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $2,000,000 | July 17, 2020 | April 30, 2025 | WYCOFF, KEITH | reporter.nih.gov |
| Commercialization Readiness Pilot (CRP) program support for: Ultra-sensitive, direct-from-blood, molecular detection of Borrelia infections. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,000,000 | April 2, 2024 | March 31, 2027 | SINGER, ALON | reporter.nih.gov |
| Targeted Prevention of Human Ehrlichiosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,991,816 | August 17, 2021 | July 31, 2027 | RIKIHISA, YASUKO | reporter.nih.gov |
| Development of an automated IVD for the ultra-sensitive, direct, molecular detection of Borrelia for early Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,972,995 | June 15, 2020 | May 31, 2024 | SINGER, ALON | reporter.nih.gov |
| A point of care vertical flow assay for the direct detection of Babesia microti and the serodiagnosis of Lyme disease. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,933,868 | July 1, 2024 | February 28, 2027 | DATTWYLER, RAYMOND JAMES | reporter.nih.gov |
| Understanding Unique Aspects of Motility and Chemotaxis in Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,906,728 | September 19, 2008 | January 31, 2027 | LI, CHUNHAO CHRIS | reporter.nih.gov |
| Discovery of early immunologic biomarkers for risk of PTLDS through machine learning-assisted broad temporal profiling of humoral immune response | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,885,162 | July 7, 2023 | June 30, 2028 | WOODBURY, NEAL WALTER | reporter.nih.gov |
| Efficacy of novel reservoir-host targeted bait formulations against a tick-borne pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,875,000 | September 1, 2021 | August 31, 2026 | SESHU, JANAKIRAM | reporter.nih.gov |
| Unlocking serology’s secrets: harnessing novel immune biomarkers to predict Lyme disease progression and recovery | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,872,987 | July 1, 2023 | June 30, 2028 | TAL, MICHAL CASPI | reporter.nih.gov |
| Virulence regulation by BadR in the Lyme disease spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,868,750 | March 24, 2021 | February 28, 2027 | OUYANG, ZHIMING | reporter.nih.gov |
| Determinants of Post-Treatment Phenotypes in Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,868,460 | July 1, 2023 | June 30, 2028 | AUCOTT, JOHN | reporter.nih.gov |
| Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,830,220 | July 5, 2023 | June 30, 2028 | HU, LINDEN T | reporter.nih.gov |
| Antiviral and immunomodulatory effects of interferon lambda in the skin | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,784,166 | March 13, 2023 | February 29, 2028 | LAZEAR, HELEN | reporter.nih.gov |
| Impacts of phenology on disease transmission dynamics | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,776,375 | August 1, 2023 | July 31, 2028 | BRISSON, DUSTIN | reporter.nih.gov |
| Antibody-mediated immunity to Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,759,416 | March 8, 2021 | February 28, 2027 | BAUMGARTH, NICOLE | reporter.nih.gov |
| Cellular and humoral immunity in Lyme arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,748,421 | January 8, 2019 | June 30, 2024 | STEERE, ALLEN C | reporter.nih.gov |
| Origin of the innate immunity suppression caused by nairovirus' protease activity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,738,279 | September 16, 2020 | August 31, 2025 | PEGAN, SCOTT DUSAN | reporter.nih.gov |
| Peptide-vaccine development against Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,724,972 | May 15, 2020 | April 30, 2026 | BARBIER, MARIETTE | reporter.nih.gov |
| Structure-based Vaccine Design for CCHFV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,714,028 | June 25, 2020 | November 30, 2025 | MCLELLAN, JASON SCOTT | reporter.nih.gov |
| Antigen Discovery and Vaccine Development for Human Babesia Parasites | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,675,000 | May 13, 2020 | April 30, 2026 | BEN MAMOUN, CHOUKRI | reporter.nih.gov |
| Leveraging environmental drivers to predict vector-borne disease transmission | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,674,900 | September 1, 2019 | March 31, 2030 | MORDECAI, ERIN | reporter.nih.gov |
| ImmunoPET Probes for the Imaging of Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,674,600 | September 19, 2023 | July 31, 2028 | ZEGLIS, BRIAN MATTHEW | reporter.nih.gov |
| Rickettsial Influence on Host Membrane Physiology in Arthropod Vectors | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,664,045 | August 25, 2021 | July 31, 2026 | SWALE, DANIEL | reporter.nih.gov |
| Emergence of tick borne encephalitis in North America | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,660,767 | December 12, 2018 | November 30, 2025 | TELFORD, SAM R | reporter.nih.gov |
| Immunomodulatory mechanisms of wild bird reservoir hosts that facilitate persistence of Lyme disease bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,654,992 | March 25, 2024 | January 31, 2029 | LIN, YI-PIN | reporter.nih.gov |
| Modulation of Host Cell Responses by Francisella tularensis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,648,413 | June 10, 2019 | May 31, 2026 | THANASSI, DAVID G | reporter.nih.gov |
| Bacterial and host factors in the pathogenesis of Lyme neuroborreliosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,636,050 | June 23, 2022 | April 30, 2027 | BRISSETTE, CATHERINE AYN | reporter.nih.gov |
| Neuroimaging and blood markers in post treatment Lyme disease with persistent neurologic symptoms | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,630,195 | September 20, 2023 | August 31, 2028 | MARVEL, CHERIE L | reporter.nih.gov |
| Translation of a highly protective tularemia vaccine to the NHP model | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,612,445 | January 15, 2024 | November 30, 2028 | HAZLETT, KARSTEN R.O. | reporter.nih.gov |
| Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,600,000 | November 1, 2021 | October 31, 2026 | MCBRIDE, JERE W | reporter.nih.gov |
| Molecular Genetics of Lyme Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,567,371 | January 15, 2020 | November 30, 2025 | WEIS, JANIS J. | reporter.nih.gov |
| Treating flaviviruses with mRNA-encoded Cas13 | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,562,785 | June 13, 2024 | May 31, 2029 | SANTANGELO, PHILIP J | reporter.nih.gov |
| Keys to prevent iron hijacking and infection by intracellular bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,560,000 | February 1, 2020 | January 31, 2026 | RIKIHISA, YASUKO | reporter.nih.gov |
| Host Factors Controlling Neuroinvasive Flavivirus Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,555,000 | August 5, 2022 | July 31, 2026 | LAZEAR, HELEN | reporter.nih.gov |
| Genetic basis for persistence of Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,547,485 | September 20, 2023 | August 31, 2028 | TOKARZ, RAFAL | reporter.nih.gov |
| Understanding the proviral role for TRAF6 interaction with the viral protease in flavivirus replication and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,545,000 | May 15, 2020 | April 30, 2025 | TAYLOR, ROGER TRAVIS | reporter.nih.gov |
| Mechanisms of Age Dependent Powassan Virus Neurovirulence | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,486,022 | December 12, 2023 | October 31, 2028 | MACKOW, ERICH R | reporter.nih.gov |
| Delineation of unique flagellar proteins in spirochetes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,479,778 | February 23, 2024 | December 31, 2028 | MOTALEB, MD A | reporter.nih.gov |
| Murine Typhus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,453,516 | September 1, 1982 | May 31, 2025 | RAHMAN, MOHAMMED SAYEEDUR | reporter.nih.gov |
| Powassan virus evolution, fitness, and pathogenesis in the Northeast and Midwest United States | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,449,322 | July 1, 2024 | June 30, 2029 | ALIOTA, MATTHEW T | reporter.nih.gov |
| CNS Senescence and Immunopathology in Lethal POWV Infection of Aged Mice | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,444,052 | August 16, 2024 | July 31, 2029 | MACKOW, ERICH R | reporter.nih.gov |
| Regulatory Network of the Lyme Disease Pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,426,161 | July 1, 2009 | May 31, 2028 | YANG, X. FRANK | reporter.nih.gov |
| Disease transmission along complex human-animal networks: a novel method for improving zoonotic disease modeling | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,403,023 | September 17, 2024 | August 31, 2029 | MEISNER, JULIANNE | reporter.nih.gov |
| An antigen-detection assay to diagnose Babesia microti infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,384,164 | January 10, 2018 | May 31, 2024 | LEDIZET, MICHEL | reporter.nih.gov |
| Borrelia burgdorferi mitogen in development of arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,372,498 | April 1, 1993 | December 31, 2025 | WEIS, JANIS J. | reporter.nih.gov |
| Isolation of broadly protective monoclonal antibodies for Crimean Congo Hemorrhagic Fever | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,356,263 | July 1, 2025 | June 30, 2029 | SAJADI, MOHAMMAD MOHSENI | reporter.nih.gov |
| Arthropod exosomes mediate vector-pathogen interactions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,311,708 | August 19, 2019 | July 31, 2026 | SULTANA, HAMEEDA | reporter.nih.gov |
| Redox Regulation of DksA-dependent Borrelia burgdorferi infectivity | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,277,811 | August 1, 2023 | July 31, 2027 | BOURRET, TRAVIS J | reporter.nih.gov |
| Chimeric epitope based vaccines for tick borne infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,255,844 | July 24, 2019 | June 30, 2024 | MARCONI, RICHARD T | reporter.nih.gov |
| Vaccines Against Ehrlichia and Anaplasma Species Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,244,930 | June 1, 2020 | December 31, 2022 | GANTA, ROMAN R. | reporter.nih.gov |
| Malaria and Mosquito/Tick-borne Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,232,416 | July 1, 2019 | July 31, 2030 | SULLIVAN, DAVID JOSEPH | reporter.nih.gov |
| Vaccines Against Ehrlichia and Anaplasma Species Infections | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $1,197,652 | June 1, 2020 | May 31, 2026 | GANTA, ROMAN R. | reporter.nih.gov |
| SCH: Machine LEarning & MicrofluiDics for Multimodal Sensing of TiCk-bOrne Diseases(MEDICO) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,194,187 | September 13, 2022 | August 31, 2027 | SRIVASTAVA, SOUMYA K | reporter.nih.gov |
| RpoS Regulation of Borrelia burgdorferi Genes in vivo | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,187,520 | April 1, 1990 | August 31, 2024 | RADOLF, JUSTIN D | reporter.nih.gov |
| Reverse-engineering a viral Swiss army knife: Crimean-Congo hemorrhagic fever virus glycoprotein functions in assembly, entry, and in vivo pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,144,171 | August 15, 2024 | July 31, 2029 | CHANDRAN, KARTIK | reporter.nih.gov |
| Development of Paratransgenic Ticks for Disease Control | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,106,078 | July 1, 2002 | November 30, 2024 | MUNDERLOH, ULRIKE GERTRUD | reporter.nih.gov |
| Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,104,705 | June 1, 2017 | May 31, 2023 | GEISBERT, THOMAS WILLIAM | reporter.nih.gov |
| Phage-mediated horizontal gene transfer in Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,101,178 | July 25, 2024 | June 30, 2029 | SECOR, PATRICK R | reporter.nih.gov |
| Anaplasma Phagocytophilum Modulate Tick Gene Expression for its Survival and Transmission from the Vector Host | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,077,124 | July 18, 2017 | June 30, 2029 | NEELAKANTA, GIRISH | reporter.nih.gov |
| Genetics and Axenic Growth of tick-borne E. chaffeensis and A. phagocytophilum | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,073,482 | July 15, 2024 | May 31, 2029 | GANTA, ROMAN R. | reporter.nih.gov |
| The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,073,058 | June 15, 2023 | May 31, 2028 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| Vector and Host Contributions to the Regulation of E. Chaffeensis Gene Expression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,072,622 | December 15, 2007 | December 31, 2022 | GANTA, ROMAN R. | reporter.nih.gov |
| Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,053,949 | August 1, 2024 | July 31, 2027 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| Molecular Basis of CD1D and Natural Killer T Cell Function | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,026,763 | August 19, 2019 | July 31, 2024 | JOYCE, SEBASTIAN | reporter.nih.gov |
| Arkansas Center for Food Allergy Research (ArCOFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $979,787 | March 14, 2024 | February 28, 2031 | JONES, STACIE M | reporter.nih.gov |
| Phylogeographic dynamics of tick-borne pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $935,188 | June 1, 2020 | May 31, 2025 | BRISSON, DUSTIN | reporter.nih.gov |
| Determination of the genetic basis for B. burgdorferi mammalian infectivity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $931,524 | June 1, 2013 | May 31, 2025 | JEWETT, MOLLIE W | reporter.nih.gov |
| Development of a vaccination platform for emerging flavivirus infections | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $919,536 | November 4, 2021 | October 31, 2026 | BECKHAM, JOHN DAVID | reporter.nih.gov |
| Regulation of glycerol utilization in Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $877,496 | June 8, 2018 | May 31, 2024 | SAMUELS, D. SCOTT | reporter.nih.gov |
| Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $876,712 | April 6, 2015 | July 31, 2023 | CLEMENTS, DAVID E | reporter.nih.gov |
| Parasite-Derived Vesicles in Babesia virulence and Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $874,372 | August 1, 2024 | July 31, 2025 | BEN MAMOUN, CHOUKRI | reporter.nih.gov |
| Development of a vaccination platform for emerging flavivirus infections | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $873,046 | November 4, 2021 | June 30, 2023 | BECKHAM, JOHN DAVID | reporter.nih.gov |
| Pathogenesis of Borrelia miyamotoi infection and Lyme coinfection in mice | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $837,500 | December 1, 2017 | November 30, 2022 | BOCKENSTEDT, LINDA K. | reporter.nih.gov |
| Mechanisms of viral RNA maturation by co-opting cellular exonucleases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $833,933 | June 1, 2022 | April 30, 2023 | KIEFT, JEFFREY S | reporter.nih.gov |
| Characterization of innate immune signaling pathways in the tick Ixodes scapularis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $831,622 | March 1, 2025 | February 28, 2030 | PERRIMON, NORBERT | reporter.nih.gov |
| At the site of the bite: Immune Response to tick-transmitted Rickettsiae | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $824,955 | February 1, 2025 | January 31, 2030 | VARELA-STOKES, ANDREA SOARES | reporter.nih.gov |
| A role for glycolipids and unconventional T cell subsets in alpha-gal allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $796,034 | June 17, 2020 | May 31, 2026 | IWEALA, ONYINYE I | reporter.nih.gov |
| Control of bacterial infections by a horizontally acquired host peptidoglycan amidase | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $795,640 | January 14, 2019 | December 31, 2022 | PANNING, BARBARA | reporter.nih.gov |
| Identification of essential factors contributing to vector colonization and transmission of relapsing fever spirochetes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $792,500 | March 1, 2018 | February 29, 2024 | LOPEZ, JOB E | reporter.nih.gov |
| Interactions of tick-borne pathogens, Borrelia burgdorferi and Babesia microti with the mammalian host using rodent model of co-infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $785,000 | August 9, 2019 | July 31, 2025 | PARVEEN, NIKHAT | reporter.nih.gov |
| Functional and Mechanistic Studies of the Role of Lp17-encoded Factors in Host Adaptation by the Lyme Disease Spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $765,000 | July 12, 2024 | June 30, 2029 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Rocky Mountain Spotted Fever Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $760,029 | September 1, 2021 | December 31, 2022 | GANTA, ROMAN R. | reporter.nih.gov |
| Molecular details of the IgE antibody response to galactose-alpha-1,3-galactose in alpha-gal syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $753,304 | March 1, 2025 | February 28, 2026 | SMITH, SCOTT ALAN | reporter.nih.gov |
| Deciphering innate and adaptive immune responses to Rickettsia parkeri | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $745,295 | June 20, 2025 | May 31, 2030 | BURKE, THOMAS P | reporter.nih.gov |
| Identification of GP38 and NP antibodies and their protective mechanisms against CCHFV | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $738,880 | September 3, 2025 | August 31, 2030 | PEGAN, SCOTT DUSAN | reporter.nih.gov |
| Outer Membrane Proteins of Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $736,700 | January 1, 2005 | December 31, 2023 | AKINS, DARRIN R. | reporter.nih.gov |
| Use of forward Genetic approaches to identify Babesia receptors | NIH | National Heart, Lung, and Blood Institute | 2021 | $710,081 | December 15, 2017 | November 30, 2022 | LOBO, CHERYL ANN | reporter.nih.gov |
| Antibody-mediated immunity to Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $673,407 | March 8, 2021 | October 1, 2022 | BAUMGARTH, NICOLE | reporter.nih.gov |
| Coping with Stress: Next Generation Approaches to Borrelia burgdorferi Host Adaptation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $661,519 | April 1, 2017 | March 31, 2023 | HU, LINDEN T | reporter.nih.gov |
| Deciphering Borrelia burgdorferi RpoS regulatory networks in ticks and mammals | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $640,129 | September 1, 2025 | August 31, 2030 | CAIMANO, MELISSA J | reporter.nih.gov |
| Developing a Potent Broad-Spectrum Prophylactic for Tickborne Disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $600,000 | July 17, 2024 | June 30, 2027 | WYCOFF, KEITH | reporter.nih.gov |
| A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitor | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $599,866 | July 8, 2024 | June 30, 2027 | FIKRIG, EROL | reporter.nih.gov |
| A therapeutic for Lyme disease based on Peptidoglycan Recognition Protein 1 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $599,028 | August 4, 2021 | July 31, 2024 | NARASIMHAN, SUKANYA | reporter.nih.gov |
| A Multivalent mRNA Vaccine to Prevent Transmission of Tick-bornePathogens | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $597,612 | May 1, 2024 | April 30, 2027 | NARASIMHAN, SUKANYA | reporter.nih.gov |
| Factor H-Fc Fusion as a Pre-Exposure Prophylactic for Rickettsia Infections | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $595,353 | July 10, 2024 | June 30, 2027 | WYCOFF, KEITH | reporter.nih.gov |
| Virulence Mechanisms of Multifunctional Borrelial Proteins | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $594,545 | June 15, 2020 | May 31, 2026 | GARCIA, BRANDON LEE | reporter.nih.gov |
| Low-cost Production of a Vaccine for Lyme Disease in Maize | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $593,524 | March 2, 2021 | February 29, 2024 | EGELKROUT, ERIN | reporter.nih.gov |
| The Ecology and Classification of Rickettsia Species Phylotype G022, an Uncharacterized Bacterium from Ixodes pacificus Ticks | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $590,000 | September 12, 2022 | August 31, 2027 | ZHONG, JIANMIN | reporter.nih.gov |
| Bioinspired mechanogating biosensors for real-time biodetection | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2024 | $577,400 | March 1, 2022 | November 30, 2025 | YAO, JUN | reporter.nih.gov |
| Generation and characterization of a large-scale transposon mutant library of Rickettsia parkeri | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $569,472 | January 2, 2024 | December 31, 2026 | GOLEY, ERIN D | reporter.nih.gov |
| The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $561,872 | June 15, 2023 | June 15, 2024 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| Transposon mutagenesis of Rickettsia for studying Rickettsia-host-vector interactions | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $558,250 | January 1, 2024 | December 31, 2026 | KIM, HWAN KEUN | reporter.nih.gov |
| Vector and Host Contributions to the Regulation of E. chaffeensis Gene | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $545,563 | December 15, 2007 | June 30, 2026 | GANTA, ROMAN R. | reporter.nih.gov |
| Novel Bacterial Small RNAs as Determinants of Rickettsial Virulence and Transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $540,869 | June 13, 2018 | May 31, 2024 | NARRA, HEMA PRASAD | reporter.nih.gov |
| Reversible transformation of Anaplasma phagocytophilum using Cre-Lox recombination | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $538,112 | January 1, 2024 | December 31, 2026 | OLIVER, JONATHAN D | reporter.nih.gov |
| Development of recombinant VSV vaccines for emerging bunyaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $532,169 | April 13, 2023 | March 31, 2026 | BATES, PAUL | reporter.nih.gov |
| Tool development for Anaplasma phagocytophilum to understand determinants of infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $527,564 | January 1, 2024 | December 31, 2026 | BRAYTON, KELLY ANN | reporter.nih.gov |
| Ehrlichia modulation of RNA splicing to influence KIRREL1-regulated Hippo signaling | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $520,128 | August 1, 2025 | July 31, 2030 | MCBRIDE, JERE W | reporter.nih.gov |
| A cross-species signaling system in tick immunity and development | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $518,099 | July 17, 2025 | June 30, 2030 | PAL, UTPAL | reporter.nih.gov |
| Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $512,455 | August 2, 2023 | July 31, 2024 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| Global Gene Expression Responses of Francisella tularensis to intracellular Infection of Human Alveolar Macrophages | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $512,020 | March 25, 2021 | February 28, 2025 | SKERRETT, SHAWN J. | reporter.nih.gov |
| Global virulence regulatory network in the Lyme disease pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $509,130 | January 2, 2025 | December 31, 2029 | OUYANG, ZHIMING | reporter.nih.gov |
| Rickettsial influence on host membrane physiology in arthropod vectors | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $508,647 | August 25, 2021 | July 31, 2022 | SWALE, DANIEL | reporter.nih.gov |
| Borrelia burgdorferi-Induced Autoimmunity in Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $503,943 | June 1, 2013 | December 31, 2022 | STEERE, ALLEN C | reporter.nih.gov |
| Microbial Determinants of Clinical Heterogeneity in Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $499,998 | July 24, 2020 | July 31, 2024 | LEMIEUX, JACOB ERIC | reporter.nih.gov |
| Understanding the Molecular Determinants of Reassortment in Orthobunyaviruses and Phleboviruses. | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $498,000 | September 2, 2020 | June 30, 2025 | TILSTON-LUNEL, NATASHA LOUISE | reporter.nih.gov |
| Repression of inflammasome by Francisella tularensis | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $480,000 | July 16, 2013 | August 31, 2027 | MALIK, MEENAKSHI | reporter.nih.gov |
| Establishing CRISPR cell screening for the deer tick Ixodes scapularis, a vector of Lyme and other diseases | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $468,950 | August 18, 2022 | July 31, 2024 | PERRIMON, NORBERT | reporter.nih.gov |
| Identification of host factors required by the tick-borne Powassan virus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $466,125 | November 23, 2020 | October 31, 2023 | RICE, CHARLES M | reporter.nih.gov |
| Identifying the Target of a Potent and Selective Inhibitor of Babesia Blood Stages. | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $466,125 | July 7, 2022 | June 30, 2025 | KAFSACK, BJORN FELIX CAESAR | reporter.nih.gov |
| Ribosome structure determination from Apicomplexan parasites | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $466,125 | May 24, 2023 | April 30, 2025 | LEGER-ABRAHAM, MELISSA | reporter.nih.gov |
| Pre-clinical studies to repurpose FDA-approved adenosine A2A receptor antagonists for lethal rickettsial infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $463,698 | June 11, 2025 | May 31, 2030 | GONG, BIN | reporter.nih.gov |
| Microfluidic Assays for Probing Neutrophil-Borrelia Interactions in Blood during Acute Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $462,000 | April 1, 2021 | March 31, 2024 | IRIMIA, DANIEL | reporter.nih.gov |
| Eliciting and isolating neutralizing antibodies against Powassan virus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $462,000 | August 1, 2021 | July 31, 2023 | LAI, JONATHAN R. | reporter.nih.gov |
| The Role the AAA+ Lon Proteases in Bacterial Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $461,823 | June 1, 2017 | May 31, 2024 | KARZAI, A. WALI | reporter.nih.gov |
| Systematic identification of interactions between Lyme Borrelia and Ixodes scapularis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $461,375 | July 1, 2025 | June 30, 2027 | FIKRIG, EROL | reporter.nih.gov |
| Immunophenotypic analysis of the cutaneous humoral response in early Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $460,625 | February 3, 2022 | January 31, 2024 | BOCKENSTEDT, LINDA K. | reporter.nih.gov |
| Contribution of RpoS to persistence of Borrelia burgdorferi in mammals | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $457,875 | July 1, 2025 | June 30, 2027 | CAIMANO, MELISSA J | reporter.nih.gov |
| Elucidating the contributions of c-di-GMP and PlzA to tick- and mammalian host-adaptation in Lyme disease spirochetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $456,886 | June 1, 2023 | May 31, 2026 | CAIMANO, MELISSA J | reporter.nih.gov |
| Investigating unknown yet essential mechanisms of gene regulation for tick-borne relapsing fever spirochetes. | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $454,791 | August 22, 2025 | July 31, 2027 | LOPEZ, JOB E | reporter.nih.gov |
| Identification of the agent of Southern Tick Associated Rash Illness | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $445,500 | March 8, 2021 | August 31, 2023 | TOKARZ, RAFAL | reporter.nih.gov |
| Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $444,125 | July 22, 2022 | June 30, 2025 | WILSON, JEFFREY M | reporter.nih.gov |
| PLURIPOTENCY OF NOVEL TICK CYSTEINE PROTEASE INHIBITORS DURING HEMATOPHAGY | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $444,000 | July 20, 2022 | June 30, 2026 | MORGAN, SARAH E | reporter.nih.gov |
| Development of a novel multipurpose model to propagate and study the tick transmission cycle of relapsing fever spirochetes from Eurasia. | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $441,375 | July 5, 2023 | June 30, 2025 | LOPEZ, JOB E | reporter.nih.gov |
| Delineating adaptive mechanisms of tick-borne relapsing fever spirochetes within the argasid vector. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $441,375 | November 21, 2023 | October 31, 2026 | LOPEZ, JOB E | reporter.nih.gov |
| Detecting released peptidoglycan fragments as a biomarker for direct diagnosis of acute and chronic Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $440,941 | March 11, 2021 | February 29, 2024 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| Infection and prevalence of a new segmented flavivirus in the United States | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $440,038 | April 13, 2021 | March 31, 2023 | KAPOOR, AMIT | reporter.nih.gov |
| Rickettsial CspA proteins and host microRNAs in exosome formation and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $440,000 | August 1, 2025 | July 31, 2027 | SOONG, LYNN | reporter.nih.gov |
| Mechanisms by which rickettsiae subvert autophagy pathway in macrophages | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $439,750 | August 4, 2021 | July 31, 2024 | FANG, RONG MEGAN | reporter.nih.gov |
| The role of RNA deletion and duplication events in Powassan virus pathogenesis and evolution | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $439,550 | February 24, 2023 | January 31, 2026 | PIANTADOSI, ANNE L | reporter.nih.gov |
| Spatial eco-epidemiology of tick-borne rickettisal pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $439,081 | August 18, 2017 | July 31, 2024 | GAFF, HOLLY | reporter.nih.gov |
| Identification of stage-and tissue-specific endogenous tick promoters | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $439,000 | August 1, 2023 | July 31, 2025 | GULIA-NUSS, MONIKA | reporter.nih.gov |
| Activation of T gamma/delta cells by Borrelia glycolipids | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $438,625 | June 4, 2021 | May 31, 2024 | BENACH, JORGE L. | reporter.nih.gov |
| Protease sensor for rapid and sensitive detection of Borrelia infections | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $436,236 | August 1, 2025 | July 31, 2027 | BOGYO, MATTHEW | reporter.nih.gov |
| The Role of YebC in persistent infection of the Lyme disease pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $435,875 | May 16, 2022 | April 30, 2025 | YANG, X. FRANK | reporter.nih.gov |
| Innate Immune Regulation of Powassan Virus Neurovirulence | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $435,263 | July 1, 2024 | October 31, 2026 | MACKOW, ERICH R | reporter.nih.gov |
| Characterizing the Pan-genome of a Rickettsia Infecting the Eastern Black-legged Tick | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $435,228 | January 22, 2021 | December 31, 2022 | GILLESPIE, JOSEPH J | reporter.nih.gov |
| Defining the roles of an enhancer long non-coding RNA eIncRNA-ID2 in rickettsial pathogenesis and immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $434,500 | January 4, 2021 | December 31, 2024 | SAHNI, ABHA | reporter.nih.gov |
| Quantitative analysis of growth in a streamlined obligate intracellular pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $434,375 | March 1, 2021 | February 29, 2024 | GOLEY, ERIN D | reporter.nih.gov |
| Basic immunological toolbox for genus Peromsycus, infection tolerant reservoirs of zoonotic agents | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $431,750 | July 1, 2025 | June 30, 2027 | BARBOUR, ALAN G. | reporter.nih.gov |
| In vitro culture of Babesia microti | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $431,143 | January 23, 2025 | December 31, 2027 | TELFORD, SAM R | reporter.nih.gov |
| Effect of Borrelia burgdorferi-SIRPalpha Interaction on the Immune Response | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $429,000 | July 17, 2025 | June 30, 2027 | COBURN, JENIFER L | reporter.nih.gov |
| Integrating population genomics and microbial metagenomics of the lone star tick, an expanding arthropod disease vector | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $428,341 | August 1, 2022 | July 31, 2025 | MONZON, JAVIER | reporter.nih.gov |
| Subversion of Keratinocyte Function by a Tick Salivary Protein | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $427,625 | February 16, 2024 | December 31, 2025 | PEDRA, JOAO | reporter.nih.gov |
| Designing a Robust Platform for the In vitro Propagation of Babesia Microti in Human RBCs | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $427,000 | December 13, 2024 | November 30, 2027 | LOBO, CHERYL ANN | reporter.nih.gov |
| Role of Borrelia Lpt Homologs in Surface Lipoprotein Secretion | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $426,250 | June 23, 2023 | May 31, 2026 | ZUECKERT, WOLFRAM R | reporter.nih.gov |
| Host-pathogen-vector interactions of R. amblyommatis for spotted fever pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $425,173 | April 15, 2022 | March 31, 2025 | KIM, HWAN KEUN | reporter.nih.gov |
| Redefining the Interaction Between Extracellular Immune Mechanisms and Intracellular Rickettsia Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $424,875 | May 25, 2021 | April 30, 2024 | RILEY, SEAN PHILLIP | reporter.nih.gov |
| Regulation of Skin Immunity by a Tick Bite | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $424,875 | November 1, 2021 | October 31, 2024 | PEDRA, JOAO | reporter.nih.gov |
| Virulent Rickettsia species utilize the CD300f phosphatidylserine-binding receptor on macrophages for host colonization and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $424,875 | August 1, 2022 | July 31, 2025 | VOSS, OLIVER | reporter.nih.gov |
| Investigating Rickettsia Interspecies and Host-Specific Lipopolysaccharide Variation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $424,875 | June 1, 2022 | May 31, 2025 | GILLESPIE, JOSEPH J | reporter.nih.gov |
| Cyclic di-GMP Second Messenger Signaling in the Tickborne Relapsing Fever Spirochete, Borrelia turicatae | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $423,883 | March 25, 2021 | February 28, 2025 | BLEVINS, JON SCOTT | reporter.nih.gov |
| Evaluating the Ability of the Invasive Asian Longhorned Tick, Haemaphysalis longicornis, to Maintain and Transmit North American Tick-borne Viruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $423,500 | August 4, 2021 | July 31, 2024 | HERMANCE, MEGHAN ELIZABETH | reporter.nih.gov |
| Exploiting the arthropod vector: novel mechanisms of Mycobacterium leprae transmission | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $423,500 | November 28, 2022 | October 31, 2025 | MACALUSO, KEVIN R. | reporter.nih.gov |
| Role of Tick Metalloprotease Inhibitors in the Transmission of Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $423,106 | August 1, 2025 | July 31, 2027 | MULENGA, ALBERT | reporter.nih.gov |
| Demonstrating the mechanism of Nairovirus translation strategy | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $423,000 | August 1, 2021 | July 31, 2025 | MIR, MOHAMMAD A | reporter.nih.gov |
| The mechanism and role of erythrocyte invasion by Francisella tularensis | NIH | National Heart, Lung, and Blood Institute | 2023 | $421,500 | May 1, 2019 | July 31, 2026 | HORZEMPA, JOSEPH A | reporter.nih.gov |
| Mechanistic and Functional Analysis of a Putative Regulatory Factor in the Lyme Disease Spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $420,750 | December 9, 2020 | November 30, 2023 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Functional and Mechanistic Studies of the VlsE-mediated Immune Avoidance System in the Lyme Disease Spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $420,750 | March 13, 2021 | February 29, 2024 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Exploratory Studies of lp17-encoded Genetic Factors Important for Tick Colonization by the Lyme Disease Spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $420,750 | March 16, 2021 | February 29, 2024 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Mutational Analysis of Putative Genetic Elements Required for Vmp Regulated Expression and Antigenic Variation by the Relapsing Fever Agent, Borrelia hermsii | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $420,750 | August 24, 2021 | July 31, 2024 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Zoonotic tick-borne pathogens contribute to acute febrile illness in rural South Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $420,426 | March 18, 2019 | February 28, 2025 | OOSTHUIZEN, MARINDA CATHARINA | reporter.nih.gov |
| Development of osmoregulation disruptors for tick control | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $418,000 | June 16, 2021 | May 31, 2023 | PARK, YOONSEONG | reporter.nih.gov |
| Adaptation of an in vitro generated human skin model for tick feeding to study Borrelia burgdorferi transmission and colonization | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $417,845 | August 1, 2025 | July 31, 2027 | BRINKWORTH, AMANDA J. | reporter.nih.gov |
| Host Ca2+, actin, and ATP production in rickettsia-endothelial cell dysfunction | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $417,621 | July 5, 2022 | June 30, 2024 | DUMLER, JOHN STEPHEN | reporter.nih.gov |
| A novel antimicrobial resistance mechanism for Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $416,625 | August 1, 2022 | July 31, 2025 | SKARE, JON T | reporter.nih.gov |
| Enrichment and validation of urine and serum-specific antigens from acute Lyme disease patient samples | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $416,448 | December 10, 2021 | November 30, 2024 | AUCOIN, DAVID P | reporter.nih.gov |
| A murine model of Lyme neuroborreliosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $414,292 | July 1, 2024 | June 30, 2027 | ROGOVSKY, ARTEM S | reporter.nih.gov |
| Pathogen-host interactions in Lyme disease interrogated at Single Cell Level | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $412,500 | April 8, 2021 | March 31, 2024 | SESHU, JANAKIRAM | reporter.nih.gov |
| Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $411,941 | August 16, 2023 | July 31, 2025 | COMUNALE, MARY ANN | reporter.nih.gov |
| Analysis of the DksA regulon in the Lyme disease spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $411,125 | March 19, 2021 | February 29, 2024 | OUYANG, ZHIMING | reporter.nih.gov |
| Characterization of vsp/vlp system of Borrelia recurrentis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $409,748 | July 5, 2024 | June 30, 2027 | ROGOVSKY, ARTEM S | reporter.nih.gov |
| Elucidating the Bacterial and Host Mechanisms Governing B. burgdorferi-Related Type I Interferon Responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $408,694 | September 15, 2021 | August 31, 2025 | HYDE, JENNY A. | reporter.nih.gov |
| The roles of Anaplasma phagocytophilum surface proteins in infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $408,604 | July 15, 2007 | June 30, 2022 | CARLYON, JASON A | reporter.nih.gov |
| Retrotransposon assay for tick host bloodmeal identification | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $407,800 | August 6, 2018 | July 31, 2023 | TELFORD, SAM R | reporter.nih.gov |
| The Role of Hemocytes in tick Rickettsia parkeri infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $407,000 | December 1, 2023 | October 31, 2026 | KARIM, SHAHID | reporter.nih.gov |
| Impacts of Borrelia burgdorferi Gac protein on infectivity and regulation of virulence protein expression | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $405,746 | June 1, 2024 | April 30, 2027 | STEVENSON, BRIAN | reporter.nih.gov |
| TICK DETERMINANTS OF POWASSAN VIRUS TRANSMISSION | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $405,000 | May 1, 2019 | April 30, 2023 | THANGAMANI, SARAVANAN | reporter.nih.gov |
| Immune response to inhalation of live attenuated vaccine in an outbred tularemia model (Resubmission) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $404,818 | January 6, 2021 | December 31, 2024 | REED, DOUGLAS SCOTT | reporter.nih.gov |
| Identification of Genetic Markers of Susceptibility to Intracellular Bacterial Infection Using the Collaborative Cross Mouse Model | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $387,137 | August 1, 2022 | July 31, 2025 | BERGMANNLEITNER, ELKE | reporter.nih.gov |
| Exploring Tr1-regulated transcription networks underpinning adaptation of pathogenic Anaplasma to the tick host | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $378,568 | July 1, 2023 | June 30, 2025 | PARK, JASON MICHAEL | reporter.nih.gov |
| Identifying novel tick attractants and repellents by exploiting their olfactory and eco-physiology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $378,500 | June 7, 2021 | May 31, 2025 | SYED, ZAINULABEUDDIN | reporter.nih.gov |
| Mechanisms of Reverse Transendothelial Migration in Arthritis Resolution | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $366,797 | September 24, 2024 | August 31, 2026 | BROWN, CHARLES R. | reporter.nih.gov |
| Clinical and viral genomic approaches to evaluate the emergence of Powassan virus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $360,788 | January 16, 2019 | December 31, 2022 | PIANTADOSI, ANNE L | reporter.nih.gov |
| Morphological and molecular identification of Hyalomma tick vectors of Crimean-Congo Hemorrhagic Fever virus | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $355,000 | June 1, 2025 | May 31, 2028 | APANASKEVICH, DMITRY A | reporter.nih.gov |
| I-Corps: Optical design and the development of high accuracy automated tick classification using computer vision | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $350,705 | April 18, 2022 | June 30, 2022 | GOODWIN, AUTUMN | reporter.nih.gov |
| A Single-Dose Long-Lasting Live-Attenuated Chimeric Vaccine Candidate Against the Emerging Tick-Borne Kyasanur Forest Disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $344,093 | August 15, 2025 | July 31, 2030 | LEE, YOUNG-MIN | reporter.nih.gov |
| Machine learning-based development of serologic test for acute Lyme disease diagnosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $300,000 | June 4, 2021 | May 31, 2022 | KELBAUSKAS, LAIMONAS | reporter.nih.gov |
| Low-dose RNA vaccine platform for tickborne flaviviruses | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $300,000 | June 15, 2022 | October 31, 2024 | MANDL, CHRISTIAN W. | reporter.nih.gov |
| Antibody isotyping for discrimination of disease stage and diagnosis of early Lyme disease. | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $295,514 | July 1, 2020 | March 31, 2023 | GOMES-SOLECKI, MARIA | reporter.nih.gov |
| A Point of Care Test for Babesia microti | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $293,142 | September 21, 2025 | August 31, 2027 | SUTHERLAND, ALAN GORDON | reporter.nih.gov |
| A viral vector-based vaccine to induce humoral and cellular immune protection against Powassan virus in a tick transmission model | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $281,786 | September 23, 2025 | August 31, 2027 | MARIN LOPEZ, ALEJANDRO | reporter.nih.gov |
| Highly-sensitive, rapid and low cost plasmonic assay platform for Lyme disease diagnosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $259,613 | August 12, 2022 | July 31, 2024 | GUIGNON, ERNEST FITCH | reporter.nih.gov |
| mRNA vaccination targeting Amblyomma ticks to prevent alpha gal syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $251,250 | February 1, 2025 | January 31, 2027 | NARASIMHAN, SUKANYA | reporter.nih.gov |
| Host heterogeneity affects susceptibility of Babesia microti infection using vector-mediated transmission | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $250,573 | March 1, 2025 | February 28, 2027 | TUFTS, DANIELLE M | reporter.nih.gov |
| Understanding the Role of Tick Phospholipase A2 in Alpha-Gal Syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $235,822 | July 23, 2025 | June 30, 2027 | KARIM, SHAHID | reporter.nih.gov |
| A PET Radiotracer for Diagnostic and Theranostics Imaging in Lyme Disease | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $234,000 | June 1, 2020 | March 31, 2022 | ZEGLIS, BRIAN MATTHEW | reporter.nih.gov |
| Investigating putative antimicrobial product biosynthesis in a tick endosymbiont. | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $232,500 | November 14, 2024 | October 31, 2026 | CULL, BENJAMIN | reporter.nih.gov |
| T4SS effectors and tick tropism in Anaplasma phagocytolium | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $229,500 | June 1, 2020 | May 31, 2023 | BRAYTON, KELLY ANN | reporter.nih.gov |
| Microbial genetic variation in the pathogenesis of Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $226,948 | March 1, 2020 | February 28, 2024 | LIN, YI-PIN | reporter.nih.gov |
| Defining human xenoglycan-specific B cells | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $225,953 | July 22, 2025 | June 30, 2027 | GUTHMILLER, JENNA | reporter.nih.gov |
| Lyme disease spirochete adhesion to tick cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $225,000 | February 18, 2020 | January 31, 2024 | RENTHAL, ROBERT D | reporter.nih.gov |
| Exploring the Collaborative Cross resource to identify different phenotypes of Lyme neuroborreliosis and disease-contributing genetic factors | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $223,105 | September 1, 2023 | May 31, 2024 | ROGOVSKY, ARTEM S | reporter.nih.gov |
| Powassan virus nanobodies from camelid monomeric variable antibody domains elicited by natural infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $211,875 | June 15, 2020 | May 31, 2022 | MACDONALD, MARGARET R | reporter.nih.gov |
| Borrelia miyamotoi meningioencephalitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $211,500 | January 1, 2020 | December 31, 2022 | BRISSETTE, CATHERINE AYN | reporter.nih.gov |
| Investigating genes of unknown function required for Rickettsia parkeri infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $210,082 | August 15, 2022 | August 14, 2025 | SIT, BRANDON YIU CHUNG | reporter.nih.gov |
| mRNA-Based Vaccines Against Tick Borne Thogotoviruses | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $207,262 | March 1, 2025 | February 28, 2027 | BOON, ADRIANUS CM | reporter.nih.gov |
| Early Host Responses During Co-Infection of Tick-Borne Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $205,469 | June 30, 2020 | May 31, 2023 | MACNAMARA, KATHERINE C. | reporter.nih.gov |
| A VSV vectored vaccine for emergent tick-born phleboviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $202,917 | March 2, 2020 | February 28, 2023 | BATES, PAUL | reporter.nih.gov |
| Skin-associated B cells in allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $201,875 | February 1, 2020 | July 31, 2022 | ERICKSON, LOREN D | reporter.nih.gov |
| Challenging the generalist paradigm: Leveraging tick chemical ecology for new control methods | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $200,625 | September 11, 2020 | August 31, 2023 | MACHTINGER, ERIKA T | reporter.nih.gov |
| Identification of the mechanism of protection against a B. burgdorferi protein CspZ for the prevention of Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $199,455 | February 1, 2020 | January 31, 2024 | LIN, YI-PIN | reporter.nih.gov |
| Developing comparative chemical genomics and genetic validation tools for Babesia spp. | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $199,375 | June 12, 2020 | May 31, 2022 | DURAISINGH, MANOJ T | reporter.nih.gov |
| Functional Impact of Stress Granules on Tick-Microbe Interactions | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $198,798 | June 9, 2020 | May 31, 2022 | SHAW, DANA KATHLEEN | reporter.nih.gov |
| Role of mTOR signaling in endothelial responses to Rickettsia rickettsii infection. | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $197,500 | February 4, 2020 | January 31, 2023 | SAHNI, ABHA | reporter.nih.gov |
| Targeting extracellular tRNA-derived RNA fragments (tRFs) to protect against fatal rickettsiosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $197,500 | June 23, 2020 | May 31, 2024 | GONG, BIN | reporter.nih.gov |
| Ehrlichia TRP120 HECT E3 ubiquitin ligase modulation of host cell pathways | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $197,500 | September 1, 2020 | August 31, 2023 | MCBRIDE, JERE W | reporter.nih.gov |
| Bourbon virus: Therapy development and Serology | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $196,875 | March 13, 2020 | February 28, 2023 | BOON, ADRIANUS CM | reporter.nih.gov |
| Advancement of a Mucosal Subunit Vaccine in an Outbred Model of Respiratory Tularemia | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $195,082 | February 18, 2020 | July 31, 2023 | BAKSHI, CHANDRA SHEKHAR | reporter.nih.gov |
| Structural Elucidation of the Novel RNA Polymerase Underlying Francisella Tularensis Virulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $194,778 | February 1, 2020 | January 31, 2022 | BRENNAN, RICHARD GERALD | reporter.nih.gov |
| Spatial case-control studies to target the human ecology of tick-borne infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $194,029 | June 10, 2020 | May 31, 2024 | LOVER, ANDREW A | reporter.nih.gov |
| Molecular basis of Wnt activation by Ehrlichia Wnt ligand mimics | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $193,422 | March 1, 2020 | February 28, 2023 | MCBRIDE, JERE W | reporter.nih.gov |
| MHC class II presentation of Borrelia burgdorferi and synovial tissue antigens in murine Lyme arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $192,500 | January 17, 2020 | December 31, 2022 | LOCHHEAD, ROBERT | reporter.nih.gov |
| Mechanisms of central nervous system invasion by the Lyme disease spirochete, Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $192,500 | April 8, 2025 | March 31, 2027 | CASSELLI, TIMOTHY | reporter.nih.gov |
| Anaplasma phagocytophilum modulates the type IV secretion system pilus to achieve tick transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $191,250 | February 20, 2020 | January 31, 2023 | BRAYTON, KELLY ANN | reporter.nih.gov |
| Mechanistic Studies of the Role of Genetic Factors in VlsE Antigenic Variation by the Lyme Disease Spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $191,250 | January 1, 2025 | December 31, 2026 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Molecular basis for anaphylaxis due to galactose-alpha-1,3-galactose (alpha-gal) | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $187,027 | June 2, 2020 | May 31, 2024 | SMITH, SCOTT ALAN | reporter.nih.gov |
| Evaluation of zoonotic reservoir hosts for severe fever with thrombocytopenia syndrome virus | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $184,423 | May 22, 2020 | April 30, 2024 | BOSCO-LAUTH, ANGELA MARIAH | reporter.nih.gov |
| Regulation of infection-associated protein expressed by the Lyme disease spirochete DnaA protein | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $184,332 | February 14, 2020 | January 31, 2024 | STEVENSON, BRIAN | reporter.nih.gov |
| FH-Fc as a Pre-Exposure Prophylactic for Tickborne Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $181,737 | July 17, 2020 | June 30, 2022 | WYCOFF, KEITH | reporter.nih.gov |
| Targeting a ubiquitous spirochete bacteriophage to prevent Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $181,250 | March 10, 2020 | February 28, 2022 | SECOR, PATRICK R | reporter.nih.gov |
| Evaluation of tafenoquine for prophylaxis of babesiosis caused by Babesia microti | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $178,000 | February 17, 2023 | January 31, 2026 | VANNIER, EDOUARD G | reporter.nih.gov |
| Exploring the Collaborative Cross resource to identify different phenotypes of Lyme neuroborreliosis and disease-contributing genetic factors | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $177,351 | September 1, 2024 | August 31, 2025 | ROGOVSKY, ARTEM S | reporter.nih.gov |
| Characterization of Francisella tularensis-specific bacteriophages | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $176,875 | April 1, 2021 | March 31, 2024 | BAKSHI, CHANDRA SHEKHAR | reporter.nih.gov |
| Novel application of isoxazoline veterinary drugs to streamline reservoir-targeted abatement of tick-borne zoonoses | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $174,610 | September 1, 2020 | August 31, 2023 | VAUGHAN, JEFFERSON ARCHER | reporter.nih.gov |
| Synovium Immunoprivilege and the Modulation of Resident Synovial Macrophage Functions in Lyme Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $167,076 | May 15, 2025 | April 30, 2030 | CYNDARI, KAREN I | reporter.nih.gov |
| Development of an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $165,000 | July 1, 2025 | June 30, 2027 | CAMILLI, ANDREW | reporter.nih.gov |
| First detection of rickettsiae in a US chigger population and the potential risk to people | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $162,839 | November 1, 2021 | April 30, 2024 | PONNUSAMY, LOGANATHAN | reporter.nih.gov |
| EGF as an environmental cue of B. burgdorferi gene regulation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $162,000 | May 5, 2025 | April 30, 2027 | HART, THOMAS | reporter.nih.gov |
| Determining the vector ecology and epidemiology of tick-borne spotted fever group Rickettsia in a large urban setting of Houston, TX. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $160,500 | February 24, 2021 | January 31, 2024 | GUNTER, SARAH MURPHY | reporter.nih.gov |
| Developing a tick-borne Rickettsia isolate library. | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $160,500 | August 1, 2025 | July 31, 2027 | GUNTER, SARAH MURPHY | reporter.nih.gov |
| A small RNA regulation of virulence in Lyme disease pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $154,500 | September 1, 2021 | August 31, 2023 | YANG, XIULI | reporter.nih.gov |
| Efferocytosis in Lyme Arthritis Resolution | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $151,930 | February 14, 2020 | June 30, 2022 | BROWN, CHARLES R. | reporter.nih.gov |
| Testing Borrelia recurrentis isolates by using a newly developed louse-borne relapsing fever mouse model | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $151,500 | July 9, 2021 | June 30, 2024 | ROGOVSKY, ARTEM S | reporter.nih.gov |
| Anaplasma phagocytophilum exploitation of regulated exocytosis. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $148,460 | May 25, 2024 | May 24, 2027 | CHIARELLI, TRAVIS JOSEPH | reporter.nih.gov |
| Evaluating Effect of Woody Plant Encroachment on Tick-borne Pathogens in the South Central United States | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $145,314 | January 20, 2022 | December 31, 2024 | NODEN, BRUCE HOWARD | reporter.nih.gov |
| Phage-mediated horizontal gene transfer in Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $144,559 | July 25, 2024 | August 9, 2024 | SECOR, PATRICK R | reporter.nih.gov |
| Identifying Determinants of Borrelia burgdorferi and Peromyscus leucopus symbiosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $143,365 | August 1, 2023 | August 2, 2025 | BOURGEOIS, JEFFREY | reporter.nih.gov |
| Isothermal Titration Calorimeter | NIH | Office of the Director, National Institutes of Health | 2024 | $143,119 | July 15, 2024 | April 15, 2025 | HUGHES, TRAVIS SHANE | reporter.nih.gov |
| Identification of linear plasmid lp36-encoded virulence determinants in the Lyme disease spirochete Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $141,000 | November 1, 2021 | October 31, 2024 | CASSELLI, TIMOTHY | reporter.nih.gov |
| Comparative effectiveness and complications of intravenous ceftriaxone compared with oral doxycycline in Lyme meningitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $137,898 | September 1, 2021 | November 30, 2021 | GARRO, ARIS C | reporter.nih.gov |
| Microbial Determinants of Clinical Heterogeneity in Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $136,350 | July 24, 2020 | June 30, 2022 | LEMIEUX, JACOB ERIC | reporter.nih.gov |
| Structural and Functional Alteration of host RBCs by Babesia | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $134,730 | December 13, 2024 | November 30, 2026 | BERI, DIVYA | reporter.nih.gov |
| Effect of Powassan virus genetic variation on replication in human cell culture and transmission by ticks | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $127,672 | August 1, 2021 | July 31, 2024 | MCMINN, REBEKAH | reporter.nih.gov |
| Application of parallel PCR and DNA sequencing for detecting remnant host DNA from the prior blood meal of Ixodes scapularis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $115,424 | March 8, 2021 | February 28, 2025 | LANDESMAN, WILLIAM | reporter.nih.gov |
| Understanding the Molecular Determinants of Reassortment in Orthobunyaviruses and Phleboviruses. | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $87,098 | September 2, 2020 | August 31, 2022 | TILSTON-LUNEL, NATASHA LOUISE | reporter.nih.gov |
| Host genetic determinants of neuroinvasive flavivirus pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $86,658 | March 1, 2022 | May 19, 2023 | JASPERSE, BRITTANY | reporter.nih.gov |
| Infectious cell entry pathway of human-infecting thogotoviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $82,366 | May 1, 2021 | May 30, 2023 | ROTHLAUF, PAUL WILLIAM | reporter.nih.gov |
| Defining the ecology of tick-borne relapsing fever Borrelia turicatae in Austin, Texas. | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $80,250 | January 1, 2020 | December 31, 2022 | LOPEZ, JOB E | reporter.nih.gov |
| Rab27 in tick extracellular vesicle biogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $77,316 | January 1, 2022 | November 2, 2023 | BUTLER, LILLIAN RAINER | reporter.nih.gov |
| Developing a system for genetic manipulation of the Old World tick-borne relapsing fever spirochete, Borrelia duttonii | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $76,000 | February 10, 2020 | January 31, 2023 | BLEVINS, JON SCOTT | reporter.nih.gov |
| Overlooked No More: Discovering Pathogens in a National Tick Collection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $74,800 | February 25, 2020 | January 31, 2022 | LITTLE, SUSAN E | reporter.nih.gov |
| Investigating the Genetic Determinants of Host-Specificity and Potential for Further Adaptation of Powassan Virus | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $73,455 | April 1, 2024 | March 31, 2026 | LANGE, RACHEL | reporter.nih.gov |
| B. burgdorferi interactions with the blood-CSF barrier: Development of a 3D choroid plexus organoid | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $70,500 | November 15, 2024 | October 31, 2026 | BRISSETTE, CATHERINE AYN | reporter.nih.gov |
| Structure and function of the Powassan Virus 3' untranslated region | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $67,692 | June 1, 2021 | April 30, 2023 | SZUCS, MATTHEW J | reporter.nih.gov |
| SeqStudio Genetic Analyzer | NIH | National Institute of General Medical Sciences | 2025 | $64,802 | August 1, 2025 | July 31, 2026 | ACHATZ, TYLER JOSEPH | reporter.nih.gov |
| Transmission of Rickettsia africae by Amblyomma americanum and Amblyommamaculatum | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $53,879 | March 10, 2020 | February 28, 2023 | MUKARATIRWA, SAMSON | reporter.nih.gov |
| Separating the molecular determinants that govern the evolution of Orthoflavivirus NS5-mediated IFN antagonism | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $49,538 | June 1, 2025 | May 31, 2028 | BEDNARSKI, EVA | reporter.nih.gov |
| Interferons and eosinophils promote liver injury during Ehrlichia-induced shock | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $49,538 | December 5, 2025 | December 4, 2027 | BAHR, AMBER | reporter.nih.gov |
| Characterization of a Lipid Receptor in Tick Humoral Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $40,662 | April 1, 2020 | March 31, 2022 | O’NEAL, ANYA JOSEPHINE | reporter.nih.gov |
| Characterizing Notch Ligand Mimic Function of the Ehrlichia TRP120 Effector in Suppression of Host Cell Apoptosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $34,831 | September 1, 2020 | August 31, 2022 | PATTERSON, LANISHA | reporter.nih.gov |
| Structural studies of virulence activation in Francisella tularensis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $33,490 | July 1, 2020 | April 30, 2022 | TRAVIS, BRADY A | reporter.nih.gov |
| Annual meeting of the American Society for Rickettsiology | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $22,000 | July 5, 2024 | June 30, 2027 | GILK, STACEY D | reporter.nih.gov |
| Application of parallel PCR and DNA sequencing for detecting remnant host DNA from the prior blood meal of Ixodes scapularis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $18,795 | March 8, 2021 | June 30, 2021 | LANDESMAN, WILLIAM | reporter.nih.gov |
| Defining the impact of complement inhibition by tick saliva in tick-borne virus evolution and adaptive immune responses in murine models of infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $13,504 | January 1, 2023 | April 1, 2023 | STONE, EMILY TAYLOR | reporter.nih.gov |
| 31st Meeting of the American Society for Rickettsiology | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $8,000 | June 23, 2022 | May 31, 2023 | MACALUSO, KEVIN R. | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Vermont & ST Agric College | Burlington, VT | 1 | $19.5 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 12 | $16.6 million | 0 | $0 |
| Washington University | Saint Louis, MO | 6 | $15 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 12 | $14.6 million | 0 | $0 |
| Yale University | New Haven, CT | 9 | $14.3 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 8 | $13.4 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 15 | $12.4 million | 0 | $0 |
| Health Research Incorporated/New York State Department of Health | Menands, NY | 2 | $10.8 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 4 | $10.1 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 4 | $9.7 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 9 | $9.7 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 7 | $7.7 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 3 | $6.8 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 5 | $6.8 million | 0 | $0 |
| Washington State University | Pullman, WA | 12 | $6.2 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 5 | $6.1 million | 0 | $0 |
| University of Maryland, College Park | College Park, MD | 5 | $6.1 million | 0 | $0 |
| University of Montana | Missoula, MT | 5 | $5.9 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 1 | $5.6 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 6 | $5.5 million | 0 | $0 |
| Institut Pasteur | Paris | 1 | $5.5 million | 0 | $0 |
| Boston College | Chestnut Hill, MA | 1 | $5.4 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 4 | $5.4 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 5 | $5.4 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 4 | $5.1 million | 0 | $0 |
| Brandeis University | Waltham, MA | 1 | $5.1 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 1 | $5 million | 0 | $0 |
| Biopeptides, Inc. | Ridgefield, CT | 2 | $5 million | 0 | $0 |
| Duke University | Durham, NC | 3 | $4.3 million | 0 | $0 |
| University of Washington | Seattle, WA | 3 | $4.2 million | 0 | $0 |
| Kansas State University | Manhattan, KS | 5 | $4.1 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 3 | $4 million | 0 | $0 |
| Helixbind, Inc. | Boxborough, MA | 2 | $4 million | 0 | $0 |
| East Carolina University | Greenville, NC | 2 | $3.8 million | 0 | $0 |
| L2 Diagnostics, LLC | New Haven, CT | 6 | $3.8 million | 0 | $0 |
| Aldatu Biosciences, Inc. | Watertown, MA | 1 | $3.7 million | 0 | $0 |
| Ohio State University | Columbus, OH | 2 | $3.6 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 3 | $3.5 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 3 | $3.5 million | 0 | $0 |
| Planet Biotechnology, Inc. | Hayward, CA | 4 | $3.4 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 5 | $3.4 million | 0 | $0 |
| Integral Molecular | Philadelphia, PA | 1 | $3.3 million | 0 | $0 |
| Immuno Technologies, Inc. | Memphis, TN | 2 | $3.3 million | 0 | $0 |
| Vectech, LLC | Baltimore, MD | 2 | $3.2 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 4 | $3.2 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 1 | $3.1 million | 0 | $0 |
| University of South Alabama | Mobile, AL | 5 | $3.1 million | 0 | $0 |
| Colorado State University | Fort Collins, CO | 3 | $3 million | 0 | $0 |
| Design-Zyme, LLC | Lawrence, KS | 1 | $3 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 2 | $2.9 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 1 | $2.9 million | 0 | $0 |
| West Virginia University Research Corporation | Morgantown, WV | 2 | $2.9 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 3 | $2.9 million | 0 | $0 |
| Board of Regents, NSHE, obo University of Nevada, Reno | Reno, NV | 3 | $2.9 million | 0 | $0 |
| University of South Florida | Tampa, FL | 3 | $2.8 million | 0 | $0 |
| Banfieldbio Inc. | Woodinville, WA | 1 | $2.8 million | 0 | $0 |
| Kephera Diagnostics, LLC | Framingham, MA | 1 | $2.8 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 4 | $2.7 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 7 | $2.5 million | 0 | $0 |
| University of Connecticut | Storrs, CT | 1 | $2.5 million | 0 | $0 |
| University of Texas at San Antonio | San Antonio, TX | 3 | $2.5 million | 0 | $0 |
| University of California-Riverside | Riverside, CA | 2 | $2.5 million | 0 | $0 |
| Cornell University | Ithaca, NY | 1 | $2.4 million | 0 | $0 |
| University of Tennessee Knoxville | Knoxville, TN | 2 | $2.4 million | 0 | $0 |
| Emory University | Atlanta, GA | 3 | $2.4 million | 0 | $0 |
| University of Rhode Island | Kingston, RI | 1 | $2.3 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 1 | $2.3 million | 0 | $0 |
| Virovax LLC | Lawrence, KS | 1 | $2.3 million | 0 | $0 |
| Triad National Security, LLC | Los Alamos, NM | 1 | $2.2 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 1 | $2.2 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 2 | $2.2 million | 0 | $0 |
| University of North Dakota Main Campus | Grand Forks, ND | 5 | $2.2 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 1 | $2.2 million | 0 | $0 |
| New York Structural Biology Center | New York, NY | 1 | $2.1 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 2 | $2.1 million | 0 | $0 |
| Stanford University | Stanford, CA | 2 | $2.1 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 4 | $2 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 2 | $2 million | 0 | $0 |
| Hunter College | New York, NY | 2 | $1.9 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 1 | $1.9 million | 0 | $0 |
| Albany Medical College | Albany, NY | 3 | $1.9 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 4 | $1.8 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 1 | $1.7 million | 0 | $0 |
| University of Florida | Gainesville, FL | 1 | $1.7 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 2 | $1.6 million | 0 | $0 |
| University of Toledo Health Sci Campus | Toledo, OH | 1 | $1.5 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 3 | $1.5 million | 0 | $0 |
| Creighton University | Omaha, NE | 1 | $1.3 million | 0 | $0 |
| New York Blood Center | New York, NY | 3 | $1.3 million | 0 | $0 |
| Montana State University | Bozeman, MT | 1 | $1.1 million | 0 | $0 |
| University of Southern Mississippi | Hattiesburg, MS | 3 | $1.1 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 3 | $1 million | 0 | $0 |
| Arkansas Children's Hospital Res Inst | Little Rock, AR | 1 | $979,787 | 0 | $0 |
| The University of Central Florida Board of Trustees | Orlando, FL | 1 | $931,524 | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 1 | $919,536 | 0 | $0 |
| Hawaii Biotech, Inc. | Honolulu, HI | 1 | $876,712 | 0 | $0 |
| Texas A&m Agrilife Research | College Station, TX | 3 | $797,711 | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 1 | $795,640 | 0 | $0 |
| Rbhs-New Jersey Medical School | Newark, NJ | 1 | $785,000 | 0 | $0 |
| University of Massachusetts Amherst | Amherst, MA | 2 | $771,429 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 155 | $93,168,373 | 0 | $0 |
| 2024 | 154 | $89,260,846 | 0 | $0 |
| 2023 | 144 | $76,708,447 | 0 | $0 |
| 2022 | 175 | $92,959,081 | 0 | $0 |
| 2021 | 176 | $81,343,728 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 2 awards here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | May 8, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 340 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 340 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 340 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 340 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 340 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 340 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 340 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.